Trinidad and Tobago currently reports a pregnant women living with hiv antiretroviral therapy coverage for pmtct of 92%, a decrease of 8% (-8.0%) from 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Trinidad and Tobago
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Trinidad and Tobago
PMTCT antiretroviral therapy coverage
More indicators for Trinidad and Tobago
Male unintentional poisoning
0.1
0.0
(2019)
Female wasting in children
7.1%
+2.5%
(2011)
Female prevalence of HIV
0.3%
+0.1%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar817
-intl dollar59
(2021)
Birth registration
96.5%
-0.1%
(2011)
Contraceptive modern method prevalence
37.6%
-0.5%
(2011)
Trinidad and Tobago PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 92% | -8% |
| 2021 | 100% | 0% |
| 2020 | 100% | +9% |
| 2019 | 91% | 0% |
| 2018 | 91% | +7% |
| 2017 | 84% | 0% |
| 2016 | 84% | +25% |
| 2015 | 59% | -5% |
| 2014 | 64% | -7% |
| 2013 | 71% | -21% |
| 2012 | 92% | +7% |
| 2011 | 85% | +19% |
| 2010 | 66% | +22% |
| 2009 | 44% | -11% |
| 2008 | 55% | +4% |
| 2007 | 51% | +4% |
| 2006 | 47% | +7% |
| 2005 | 40% | +6% |
| 2004 | 34% | -1% |
| 2003 | 35% | +6% |
| 2002 | 29% | +7% |
| 2001 | 22% | +13% |
| 2000 | 9% |